Validated spectrofluorimetric method for the determination of tamsulosin in spiked human urine, pure and pharmaceutical preparations
dc.authorid | 0000-0003-2759-4411 | |
dc.authorscopusid | 55235059200 | |
dc.authorscopusid | 34574169900 | |
dc.authorwosid | karasakal, ayca/ABA-4762-2020 | |
dc.contributor.author | Karasakal, Ayça | |
dc.contributor.author | Ulu, Sevgi Tatar | |
dc.date.accessioned | 2022-05-11T14:29:57Z | |
dc.date.available | 2022-05-11T14:29:57Z | |
dc.date.issued | 2014 | |
dc.department | Fakülteler, Fen Edebiyat Fakültesi, Kimya Bölümü | |
dc.description.abstract | A novel, sensitive and selective spectrofluorimetric method was developed for the determination of tamsulosin in spiked human urine and pharmaceutical preparations. The proposed method is based on the reaction of tamsulosin with 1-dimethylaminonaphthalene-5-sulfonyl chloride in carbonate buffer pH10.5 to yield a highly fluorescent derivative. The described method was validated and the analytical parameters of linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy, precision, recovery and robustness were evaluated. The proposed method showed a linear dependence of the fluorescence intensity on drug concentration over the range 1.22 x 10(-7) to 7.35 x 10(-6)M. LOD and LOQ were calculated as 1.07 x 10(-7) and 3.23 x 10(-7)M, respectively. The proposed method was successfully applied for the determination of tamsulosin in pharmaceutical preparations and the obtained results were in good agreement with those obtained using the reference method. Copyright (c) 2013 John Wiley & Sons, Ltd. | |
dc.identifier.doi | 10.1002/bio.2534 | |
dc.identifier.endpage | 242 | |
dc.identifier.issn | 1522-7235 | |
dc.identifier.issn | 1522-7243 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 23847119 | |
dc.identifier.scopus | 2-s2.0-84898770865 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 239 | |
dc.identifier.uri | https://doi.org/10.1002/bio.2534 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/7183 | |
dc.identifier.volume | 29 | |
dc.identifier.wos | WOS:000334346000006 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Karasakal, Ayça | |
dc.language.iso | en | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | Luminescence | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | derivatization | |
dc.subject | human urine | |
dc.subject | method validation | |
dc.subject | dansyl chloride | |
dc.subject | Performance Liquid-Chromatography | |
dc.subject | Human Plasma | |
dc.subject | Mass-Spectrometry | |
dc.subject | Sensitive Method | |
dc.subject | Hydrochloride | |
dc.title | Validated spectrofluorimetric method for the determination of tamsulosin in spiked human urine, pure and pharmaceutical preparations | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 7183.pdf
- Boyut:
- 256.17 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text